Abstract
Unstructured scientific data is one of the biggest drains on productivity in the pharmaceutical industry today, at an estimated impact of €10 billion per year. In this talk we will explore the hidden costs that data silos and proprietary file formats have—from manual data-cleansing to compliance to enterprise-wide digital transformation. In addition, we will discuss why open data standards and technologies that adhere to the FAIR principles of findability, accessibility, interoperability, and reusability are key enablers for innovations based on AI, ML, advanced analytics, and more.
What Does it Cover?
- Data-driven business models
- Using standards to integrate instruments with LIMS and ELN
- Storing instrument data in the cloud
- Converting instrument data into the open AnIML format
- Controlling instruments using SiLA
- Data Integrity
What Will You Learn?
- Learn more about how open standards can actually be used
- Learn how data integration and standardization can accelerate speed to market
- Learn more about the direct and indirect business impacts of your organization’s data policies
Speaker
Hayden Boehm
Merck
Head of Commercial Marketing
Haydn Boehm has over 20 years of experience in marketing and business development within the Life Scientific sector. He has a Ph.D. in Organic Chemistry from the University of Nottingham, UK.
Research and disease areas
- Pharmacology and drug discovery research
Duration:57min
Language:English
Session 1:presented April 14, 2021
To continue reading please sign in or create an account.
Don't Have An Account?